Litcius/Paper detail

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability

Deborah L. Burnett, Katherine Jackson, David B. Langley, Anupriya Aggarwal, Alberto Ospina Stella, Matt D. Johansen, Harikrishnan Balachandran, Helen Lenthall, Romain Rouet, Gregory J. Walker, Bernadette M. Saunders, Mandeep Singh, Hui Li, Jake Y. Henry, Jennifer Jackson, Alastair G. Stewart, Franka Witthauer, Matthew A. Spence, Nicole G. Hansbro, Colin J. Jackson, Peter Schofield, Claire Milthorpe, Marianne Martinello, Sebastian Schulz, Edith Roth, Anthony D. Kelleher, Sean Emery, Warwick J. Britton, William D. Rawlinson, Rudolfo Karl, Simon T. Schafer, Thomas Winkler, Robert Brink, Rowena A. Bull, Philip M. Hansbro, Hans‐Martin Jäck, Stuart Turville, Daniel Christ, Christopher C. Goodnow

2021Immunity55 citationsDOIOpen Access PDF

Topics & Concepts

AntibodyBiologyVirologyNeutralizing antibodyAntibody RepertoireEpitopeNeutralizationConserved sequenceImmunologyGeneticsPeptide sequenceGeneSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchViral gastroenteritis research and epidemiology
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability | Litcius